Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Location status: Recruiting
NCT Number: NCT06695247
The purpose of this study is to develop a unique structure and delivery of home-based exercise through multidisciplinary expertise of cardiovascular medicine specialists and cardiac physiologists using an Interactive Care Plan.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Acute intermediate-risk PE, defined as:
Acute high-risk PE, defined as:
Exclusion criteria
Patients will be recommended to exercise 3 days/week, 20 minutes per session, for 12 weeks using personalized intervention determined by a consultation with a clinical exercise physiologist (CEP)
Time frame: Baseline, 3 Months, 6 Months
Physical capacity will be determined by 6-minute walk distance (6MWD)
Time frame: Baseline, 3 Months, 6 Months
The Pulmonary Embolism-specific quality of life questionnaire assesses 6 quality of life dimensions in individuals with history of PE: frequency of symptoms, intensity of symptoms, activities of daily living limitations, social limitations, emotional distress, and work-related problems. Higher scores indicate worse quality of life.
Time frame: Baseline, 3 Months, 6 Months
The Short Form 36 (SF-36) questionnaire assesses 8 quality of life dimensions: physical activity limitations, social activities limitations, activities of daily living physical limitations, bodily pain, general mental health, activities of daily living emotional limitations, vitality, and general health perceptions. Higher scores indicate better quality of life.
Time frame: Baseline, 3 Months, 6 Months
Number of Steps will be determined by fitbit tracking with Fitabase.
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
Mobility Outcomes in Post-Pulmonary Embolic Disease (MOPED): A Pilot Feasibility Prospective Randomized Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07350499
Arterial Thromboembolism, Cardiovascular Diseases
Huntsville, Alabama, United States
View Trial DetailsNCT06041594
Cardiovascular Diseases, Embolism
Birmingham, Alabama, United States
View Trial DetailsNCT06433011
Cardiovascular Diseases, Embolism
Scottsdale, Arizona, United States
View Trial DetailsNCT06588634
Cardiovascular Diseases, Embolism
New Haven, Connecticut, United States
View Trial Details